182 related articles for article (PubMed ID: 9582514)
41. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
42. Dexamethasone enhances insulin-like growth factor-I effects on skeletal muscle cell proliferation. Role of specific intracellular signaling pathways.
Giorgino F; Smith RJ
J Clin Invest; 1995 Sep; 96(3):1473-83. PubMed ID: 7544807
[TBL] [Abstract][Full Text] [Related]
43. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
45. Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation.
Greene MW; Garofalo RS
Biochemistry; 2002 Jun; 41(22):7082-91. PubMed ID: 12033942
[TBL] [Abstract][Full Text] [Related]
46. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
Tsuruzoe K; Emkey R; Kriauciunas KM; Ueki K; Kahn CR
Mol Cell Biol; 2001 Jan; 21(1):26-38. PubMed ID: 11113178
[TBL] [Abstract][Full Text] [Related]
47. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
48. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
[TBL] [Abstract][Full Text] [Related]
49. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
50. Developmental expression of insulin receptor substrate-2 during dimethylsulfoxide-induced differentiation of human HL-60 cells.
Schacher DH; VanHoy RW; Liu Q; Arkins S; Dantzer R; Freund GG; Kelley KW
J Immunol; 2000 Jan; 164(1):113-20. PubMed ID: 10605001
[TBL] [Abstract][Full Text] [Related]
51. Augmented growth response to IGF-1 via increased IRS-1 in Chinese hamster ovary cells expressing kinase-negative insulin receptors.
Inoue S; Fukuda K; Kudara T; Igura T; Inui Y; Tamura S; Hanafusa T; Kawata S; Matsuzawa Y
Diabetologia; 1999 Jun; 42(6):763-72. PubMed ID: 10382598
[TBL] [Abstract][Full Text] [Related]
52. A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth.
Schuppin GT; Pons S; Hügl S; Aiello LP; King GL; White M; Rhodes CJ
Diabetes; 1998 Jul; 47(7):1074-85. PubMed ID: 9648831
[TBL] [Abstract][Full Text] [Related]
53. Insulin receptor substrate 1 mediates insulin and insulin-like growth factor I-stimulated maturation of Xenopus oocytes.
Chuang LM; Myers MG; Seidner GA; Birnbaum MJ; White MF; Kahn CR
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5172-5. PubMed ID: 7685118
[TBL] [Abstract][Full Text] [Related]
54. Effect of receptor phosphorylation on the binding between IRS-1 and IGF-1R as revealed by surface plasmon resonance biosensor.
Huang M; Lai WP; Wong MS; Yang M
FEBS Lett; 2001 Sep; 505(1):31-6. PubMed ID: 11557037
[TBL] [Abstract][Full Text] [Related]
55. Insulin and insulin-like growth factors stimulate in vivo receptor autophosphorylation and tyrosine phosphorylation of a 70K substrate in cultured fetal chick neurons.
Kenner KA; Heidenreich KA
Endocrinology; 1991 Jul; 129(1):301-11. PubMed ID: 1711464
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factor-mediated phosphorylation and protooncogene induction in Madin-Darby canine kidney cells.
Hauguel-de Mouzon S; Kahn CR
Mol Endocrinol; 1991 Jan; 5(1):51-60. PubMed ID: 1708099
[TBL] [Abstract][Full Text] [Related]
57. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
58. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
Perrault R; Wright B; Storie B; Hatherell A; Zahradka P
Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
[TBL] [Abstract][Full Text] [Related]
59. Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells.
Ali MS; Schieffer B; Delafontaine P; Bernstein KE; Ling BN; Marrero MB
J Biol Chem; 1997 May; 272(19):12373-9. PubMed ID: 9139682
[TBL] [Abstract][Full Text] [Related]
60. Alcohol impairs insulin and IGF-I stimulation of S6K1 but not 4E-BP1 in skeletal muscle.
Kumar V; Frost RA; Lang CH
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E917-28. PubMed ID: 12376318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
